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Abstract: 
In this article, we derive the limit of detection for a two-step molecular recognition process and 
show that in-spite of all the recognition reactions being in equilibrium the overall error rates 
can be reduced exactly as much as possible in non-equilibrium methods such as kinetic proof-
reading.  
 
Introduction: 
 
Biological systems can operate with extraordinary precision. Single cells can detect a change 
in concentration as low as 3.2nM [1]. DNA polymerase in some bacteria operates with a 
mutation rate of 1 error per 100 million to 1 billion nucleotides [2]. Surprisingly, these systems 
achieve this in an extremely noisy environment, where the concentration of the molecules of 
interest can be several orders of magnitude lower than the other molecules present in the 
environment. Mathematical analysis of these systems suggest that it is theoretically impossible 
to achieve such precision with equilibrium biochemical reactions [3]. To address this 
discrepancy between theory and experimental evidence, a biochemical proofreading scheme 
was proposed by J.J. Hopfield [4]. In his seminal work, Hopfield argued that addition of a non-
equilibrium step in the biochemical process can significantly improve the specificity of the 
system and therefore, improve the precision.  
 
Similar to biological systems, artificially engineered biomarker detection systems (clinical 
biosensors) also struggle with the presence of spurious molecules in bodily fluids. Typically, 
these clinical biosensors have a sensing surface coated with receptor molecules which are 
obtained in the form of antibodies produced in vivo against the biomarker of interest. 
Therefore, the binding affinity of the receptors towards the biomarker is higher than other 
biomolecules in the serum. However, because of the in-vivo selection process, these receptors 
are also often cross-reactive. Even though these antibodies are screened only against the 
biomarker of interest, in many cases, they have binding affinity towards several unrelated 
antigens present in the serum [5]. Therefore, in a biomarker detection process one also needs 
to consider the noise due to the binding of spurious molecules to the receptors. 
 
In a previous work [6], we have calculated the limit of detection of a clinical biosensor in an 
experimentally relevant situation. Our analysis showed that if the concentration of the receptors 
is not known to infinite precision, then the choice of the read-out technique has a large effect 
on the performance of the biosensor, particularly the fidelity of measurement. With uncertainty 
in the receptor concentration, a read-out technique with minimum signal background from the 
unbound receptors performs better. This result explains the lower     of fluorescence-based 
techniques such as ELISA compare to label-free techniques. With an optimal read-out 
technique which minimizes the background from unbound receptors, the performance of a 
biosensor is then limited by the fluctuation in the concentration of the spurious molecules 
present in the serum. The limit of detection (   ) of such a system can be written as 
 
     = √2    
 
(1) 
Experimental evidence suggests that this limit of detection can be significantly improved by 
adding a second step where a label molecule is introduced into the system. Similar to the 
receptors, these label molecules have a higher binding affinity towards the biomarker of interest 
and therefore selectively binds to them. Interestingly, addition of the second molecule in these 
system mimics the effect of proofreading in cellular sensing systems, even though, unlike 
Hopfield’s proofreading schemes, all the reactions in case of the two-step diagnostic processes 
are in equilibrium. In this article, we derive a general expression for the limit of detection of a 
two-step diagnosis process. In the light of the results in our previous work, we will then limit 
ourselves to the analysis of fluorescence-based two-step detection techniques to study the 
effects of addition of a label molecule in the sensing system. We will conclude our analysis by 
comparing a two-step diagnosis process with traditional non-equilibrium proofreading 
schemes.  
 
Mathematical model 
 
Let us consider a two-step biomolecular detection system using a fluorescent label even though 
the approach here is applicable to any other labels such as enzymes in the case ELISA. The 
first step is to pour the serum over a surface where receptors are immobilized.  Ideally, this 
should cause biomarkers to specifically attach to the surface. However, non-specific antigens 
present in the serum also get attached to the surface due to the low specificity of the receptors. 
Therefore, in the second step, a fluorescently labeled antibody is applied over the surface. 
Similar to [6], to detect the presence of specific biomarkers in the serum, a baseline 
measurement is done with healthy serum and is compared with the serum to be tested. If   and 
   are the output signals from experiments in presence and absence of specific ligands 
respectively, then the generic expressions for   and    can be written as 
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Where    is the concentration of the receptor molecules,  
( ) and   
( )
	 are the fractions of bound 
receptors in present and absent of specific ligands and   
( )
 and    are the signal strength due 
to bound and unbound receptors respectively. The superscripts 1 and 2 represent the 1st and 2nd 
step respectively. For example,  ( ) is fraction of receptors which are bound with the labels 
and  ( ) is the fraction of receptors which are only bound with the ligands but not with the 
label. Similarly,   
( )
 and   
( )
 represent the signal due to the receptors which are bound only 
by the ligand molecules and receptors which are bound with both ligand molecules and labels 
respectively. The parameter   is the measurement noise, which is defined as   =     ,   
  . 
   is the average fluorescence due to the binding of the label molecules to the sensor surface 
and   
  is the variance in the measured parameter due to the noise in the measurement system.  
 
The parameters  ( ) and   
( )
 can be defined as 
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where    is the dissociation constant for the ligand-fluorescent label interaction,   
   is the 
dissociation constant for the ligand-receptor interaction and the subscripts  ,  ,  	and   
represent receptors, specific ligands, non-specific ligands and labels respectively. Typical 
biosensors have receptor concentration much larger than the specific and non-specific ligand 
concentrations to avoid undetectability in presence of measurement noise [6]. Therefore, the 
expression for  ( ) and   
( )
 in equation (3) can be rewritten as 
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Similar to [6], to consider the effects of the fluctuations in the concentrations of receptor and 
non-specific ligand molecules, we have assumed    and    as Gaussian distributions defined 
as 
   =       1 + (0,   
 )  
   =       1 + (0,   
 )  
 
In a real-life scenario, the concentration of the fluorescent labels depends on the probability 
that a label molecule is tagged with the fluorescent molecules. However, it is always possible 
to eliminate the noise generated by the stochasticity of tagging by selecting only the tagged 
molecules. Therefore, without loss of generality, we can safely assume the concentration of 
label molecules (  ) to be constant. Therefore, following the derivation in [6], the     of a 
two-step biomarker sensor can be written as 
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      ( )/2 , where   is the Q-function and   ( ) is the probability of error with infinite 
measurements.    
 
 
Results and discussion: 
 
We can retrieve the limit of detection of a one-step detection system [6] from equation (5) for 
   = 0. Similar to the one-step detection system, the limit of detection in case of a two-step 
system     ( )  also explicitly depends on the parameters  ,   ,   	and   . As a result, the 
effects of these parameters on the limit of detection remain unchanged after the addition of the 
second step. In contrast, the parameter    
( )
  has exactly the opposite effect than it had in the 
one-step system. To achieve a lower limit of detection in case of a one-step system,    
( )
  
needed to be high. Instead, in case of a two-step system, optimal limit of detection can be 
achieved by minimizing    
( )
  while maximizing    
( )
 . [Fig 1a] Therefore, for an optimal 
two-step biomarker detection system,    =   
( )
= 0. For such a system, the limit of detection 
becomes 
       
( )
= √2     
(6) 
 
Where   =
      
      
 and    =   /      
 
[Figure 1: a. Effect of   
( ) on the limit of detection. For the case of a two-step diagnosis process, 
decreasing   
( ) reduces the     and hence makes the system more efficient. 
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    ,   =  .   ,    =    =  .   	b. Effect of concentration of label molecules on the optimal 
limit of detection (      
( ) ) for a two-step system for different values of   . The dotted lines 
represent the limit detection for a one-step system for the same values of   . Introducing a 
second step improves the limit of detection of a system for very small concentration of label 
molecules. Interestingly, increasing the concentration of the label molecules increases the limit 
of detection and eventually converges with the limit of detection of a one-step system for very 
large concentration of label molecules.           	    :   =  .   ,    =   
  ,    =
    	] 
 
Figure (1b) shows the effect of    on the limit of detection. One interesting aspect of equation 
(6) is that       
( )
 converges to the (   )    calculated in equation (10) of [6] for    ≫    . 
Therefore, adding a large concentration of label molecules doesn’t increase specificity of the 
optimal detection system. One could intuitively interpret this in the following manner. In case 
of    ≫    , because of the abundance of the fluorescent labels, there will be no competition 
between the specific and non-specific ligands for binding to the labels. Therefore, the labels 
will bind to all the binding sites with equal probability and the assay will get saturated. On the 
other hand, addition of label molecules in very low concentration can improve the     
significantly. Comparing       
( )
 with        derived in [6] for    ≪    , we get 
       
( )
=         
( )
 (7) 
 
We can compare this result with the kinetic proofreading scheme described by Hopfield [4].  
Hopfield demonstrated that the probability of formation of an error product of an equilibrium 
Michaelis-Menten system can be improved by addition of a non-equilibrium step. His results 
suggest that the maximum possible improvement in specificity in a such a system will be of 
the order of   , where    is the ratio of the dissociation constants of the correct and error 
reactants. Although, results in equation (7) is similar to Hopfield’s results, unlike Hopfield’s 
model, all the reaction kinetics in this case are in equilibrium. One can consider the addition of 
the label molecule into the system as the out-of-equilibrium step in the process as it breaks the 
law of conservation of mass. In fact, addition of the label molecule provides additional 
information and thereby decreases the entropy of the system. Therefore, the two-step diagnosis 
system doesn’t need a non-equilibrium step to achieve a higher specificity. 
  
Conclusion: 
 
In [6], we had calculated the limit of detection of a one-step biomolecular detection system. 
We showed that under optimal experimental conditions, the     is limited by the fluctuation 
in the concentration of the non-specific ligand molecules present in the serum. In this article 
we extended the analysis to two-step detection systems where a label molecule is added to the 
system as a second step. Our results show that addition of label molecule in small concentration 
can reduce the     significantly as observed in commercially available systems such as 
ELISA. Surprisingly, addition of large concentration of label molecules results in no 
measurable change in the     of the system.  
 
Our analysis provides a mathematical framework for designing two-step biomarker detection 
systems. We demonstrated that for optimal two-step systems, the contrast between the signals 
due to the unbound receptors and receptors bound only in the first step of the process needs to 
be minimized. Therefore, detection systems that perform poorly as one-step systems, can be 
excellent candidates for a two-step detection system.  
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